title: [Prostate biopsy: which strategy for which patient?].
abstract: The adoption of multiparametric MRI within the diagnostic pathway has allowed urologists to move from random biopsy to targeted biopsy directed towards MR-visible lesions. The use of software for MR to TRUS fusion may enhance the diagnostic accuracy of targeted biopsy. To determine the eligibility for tissue-preserving approaches, further precision is required, and template prostate mapping biopsy may be offered. The employment of novel biopsy techniques provide better characterisation of the disease, and allows a tailored approach to a single subject.
authors.forename: Rodolfo
authors.initials: R
authors.lastname: Burruni
authors.forename: Yannick
authors.initials: Y
authors.lastname: Cerantola
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Meuwly
authors.forename: Thomas
authors.initials: T
authors.lastname: Tawadros
authors.forename: Patrice
authors.initials: P
authors.lastname: Jichlinski
authors.forename: Massimo
authors.initials: M
authors.lastname: Valerio
mesh_terms: D001706:Biopsy; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D018579:Patient Selection; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000473:pathology